Oxford Nanopore Technologies announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products. Never miss a story ...

MinION Mk1D is a real-time, portable sequencer that can be used anywhere, lowering the barrier to access genomic information. Utilizing a single MinION Flow Cell, this small device can sequence both ...

Oxford Nanopore Technologies (ONT) has reported a steady performance in its 2024 Half Year Interim Results, with CEO Gordon Sanghera confirming the company's alignment with ...

I'm Gordon Sanghera, Chief Executive of Oxford Nanopore ... 74% of our revenues are from our consumable sales of flow cells and kits. Our gross margin for the period was 58.8%, up 120 basis ...

This total includes a £50mn strategic investment from Novo Holdings, the investment vehicle of weight-loss drugmaker Novo Nordisk (DN:NOVO.B). Oxford Nanopore expects to reach the crucial Ebitda break ...

1 Day ONTTF 5.43% DJIA 0.72% S&P Mid Cap 400 1.71% Health Care/Life Sciences -0.83% ...

(Bloomberg) -- Oxford Nanopore Technologies Plc, the DNA-sequencing firm whose shares have plunged since going public, is setting its sights on FTSE 250 index inclusion that would widen the pool ...

(Sharecast News) - Oxford Nanopore Technologies reported a steady ... breakeven by the 2027 financial year, and becoming cash flow positive by 2028. "Against a challenging backdrop, our financial ...

Oxford Nanopore Technologies Plc, the DNA-sequencing firm whose shares have plunged since going public, is setting its sights on FTSE 250 index inclusion that would widen the pool of potential ...

Dr. Preston will join the Nominating and Corporate Gove It's been a pretty great week for Oxford Nanopore Technologies plc ( LON:ONT ) shareholders, with its shares surging... Oxford Nanopore ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...